Pharma Company Cipla
-
{
- All
- News
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Delhi High Court Asks Pharma Companies, Centre to Resolve the Drug Pricing
A bench of Justice B D Ahmed and Justice Vibhu Bakhru said representatives of the pharma companies hold a meeting with the Director of the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, to settle the matter "once and for ever".
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Cipla Shifts Focus To India To Drive Growth
Cipla is looking at a billion dollar consolidated revenue for the domestic market in FY19.
-
Cipla Shifts Focus To India To Drive Growth
Cipla is looking at a billion dollar consolidated revenue for the domestic market in FY19.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Delhi High Court Asks Pharma Companies, Centre to Resolve the Drug Pricing
A bench of Justice B D Ahmed and Justice Vibhu Bakhru said representatives of the pharma companies hold a meeting with the Director of the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, to settle the matter "once and for ever".
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Cipla Shifts Focus To India To Drive Growth
Cipla is looking at a billion dollar consolidated revenue for the domestic market in FY19.
-
Cipla Shifts Focus To India To Drive Growth
Cipla is looking at a billion dollar consolidated revenue for the domestic market in FY19.
